Page last updated: 2024-08-25

bexarotene and Cancer of Prostate

bexarotene has been researched along with Cancer of Prostate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lamph, WW; Yen, WC	1

Other Studies

1 other study(ies) available for bexarotene and Cancer of Prostate

Article	Year
A selective retinoid X receptor agonist bexarotene (LGD1069, Targretin) prevents and overcomes multidrug resistance in advanced prostate cancer. The Prostate, 2006, Feb-15, Volume: 66, Issue:3 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bexarotene; Cell Line, Tumor; Cell Proliferation; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Male; Mice; Mice, Nude; Paclitaxel; Prostatic Neoplasms; Retinoid X Receptors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Tetrahydronaphthalenes	2006

Article

Year

A selective retinoid X receptor agonist bexarotene (LGD1069, Targretin) prevents and overcomes multidrug resistance in advanced prostate cancer.

The Prostate, 2006, Feb-15, Volume: 66, Issue:3

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bexarotene; Cell Line, Tumor; Cell Proliferation; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Male; Mice; Mice, Nude; Paclitaxel; Prostatic Neoplasms; Retinoid X Receptors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Tetrahydronaphthalenes

2006